NASDAQ:TCRX | Key Financial Ratios | TScan Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-303.370.47-68.66%-170.55%
2026-03-316.65-61.54%-128.25%
2025-12-318.41-56.72%-105.40%
2025-09-306.44-54.38%-99.01%
2025-06-307.06-45.81%-77.40%
2025-03-318.55-39.52%-62.55%
2024-12-318.14-34.36%-52.91%
2024-09-309.56-31.98%-48.59%
2024-06-307.770.12-27.85%-40.91%
2024-03-315.230.25-40.19%-78.72%
2023-12-316.510.2-32.78%-59.14%
2023-09-306.560.18-30.31%-52.28%
2023-06-306.9-25.74%-42.80%
2023-03-317.18-41.84%-93.09%
2022-12-317.17-33.26%-66.60%
2022-09-308.51-37.29%-52.89%
2022-06-307.53-40.21%-46.56%
2022-03-317.89-33.81%-39.03%
2021-12-317.76-25.85%-30.24%
2021-09-308.15-20.61%-24.26%
2021-06-305.34-25.82%55.91%
2021-03-3157.09%
2020-12-312.09

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-318.41-56.72%-105.40%
2024-12-318.14-34.36%-52.91%
2023-12-316.510.2-32.78%-59.14%
2022-12-317.17-33.26%-66.60%
2021-12-317.76-25.85%-30.24%
2020-12-312.09-52.53%61.53%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.